Genmab A/S (LON:0MGB)
London · Delayed Price · Currency is GBP · Price in DKK 1,857.70
+12.22 (0.66%)
At close: Oct 31, 2025
Genmab Market Cap
Genmab has a market cap or net worth of 13.48 billion as of November 4, 2025. Its market cap has increased by 18.79% in one year.
Market Cap
13.48B
Enterprise Value
11.43B
Revenue
2.66B
Ranking
n/a
PE Ratio
13.47
Stock Price
1,857.70
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 287.00M to 13.48B, an increase of 4,597.38%. That is a compound annual growth rate of 16.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 13.31B | 26.20% |
| Dec 30, 2024 | 10.54B | -35.66% |
| Dec 29, 2023 | 16.39B | -28.50% |
| Dec 30, 2022 | 22.92B | 18.07% |
| Dec 30, 2021 | 19.41B | -0.78% |
| Dec 30, 2020 | 19.57B | 77.54% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| HSBC Holdings | 182.59B |
| Shell | 164.70B |
| Unilever | 114.25B |
| Rolls-Royce Holdings | 98.20B |
| Rio Tinto Group | 93.32B |
| British American Tobacco p.l.c. | 84.99B |
| GSK plc | 71.57B |